These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10713674)
1. Genetic variants of CYP19 (aromatase) and breast cancer risk. Kristensen VN; Harada N; Yoshimura N; Haraldsen E; Lonning PE; Erikstein B; Kåresen R; Kristensen T; Børresen-Dale AL Oncogene; 2000 Mar; 19(10):1329-33. PubMed ID: 10713674 [TBL] [Abstract][Full Text] [Related]
2. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women. Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193 [TBL] [Abstract][Full Text] [Related]
3. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers. Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591 [TBL] [Abstract][Full Text] [Related]
4. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421 [TBL] [Abstract][Full Text] [Related]
5. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews. Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906 [TBL] [Abstract][Full Text] [Related]
6. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304 [TBL] [Abstract][Full Text] [Related]
7. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475 [TBL] [Abstract][Full Text] [Related]
8. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese. Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966 [TBL] [Abstract][Full Text] [Related]
9. CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women. Ribeiro FS; de Amorim LM; de Almeida Simão T; Mendonça GA; de Moura Gallo CV; Pinto LF Toxicol Lett; 2006 Jun; 164(1):90-5. PubMed ID: 16406421 [TBL] [Abstract][Full Text] [Related]
10. A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides. Dialyna I; Tzanakakis G; Dolapsakis G; Tsatsakis A Toxicol Lett; 2004 Jun; 151(1):267-71. PubMed ID: 15177662 [TBL] [Abstract][Full Text] [Related]
11. Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population. Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Yamanaka H Anticancer Res; 2003; 23(6D):4941-6. PubMed ID: 14981949 [TBL] [Abstract][Full Text] [Related]
12. Aromatase gene expression in adipose tissue: relationship to breast cancer. Simpson ER; Mahendroo MS; Nichols JE; Bulun SE Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():75-83. PubMed ID: 7874190 [TBL] [Abstract][Full Text] [Related]
13. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674 [TBL] [Abstract][Full Text] [Related]
14. Polymorphic variation in CYP19 and the risk of breast cancer. Baxter SW; Choong DY; Eccles DM; Campbell IG Carcinogenesis; 2001 Feb; 22(2):347-9. PubMed ID: 11181459 [TBL] [Abstract][Full Text] [Related]
15. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857 [TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients. Fasching PA; Loehberg CR; Strissel PL; Lux MP; Bani MR; Schrauder M; Geiler S; Ringleff K; Oeser S; Weihbrecht S; Schulz-Wendtland R; Hartmann A; Beckmann MW; Strick R Breast Cancer Res Treat; 2008 Nov; 112(1):89-98. PubMed ID: 18049890 [TBL] [Abstract][Full Text] [Related]
17. Organization of the human aromatase p450 (CYP19) gene. Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study. Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L; Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714 [TBL] [Abstract][Full Text] [Related]
19. Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women. Corbo RM; Gambina G; Ulizzi L; Moretto G; Scacchi R Dement Geriatr Cogn Disord; 2009; 27(6):513-8. PubMed ID: 19478482 [TBL] [Abstract][Full Text] [Related]
20. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Dick IM; Devine A; Prince RL Am J Physiol Endocrinol Metab; 2005 May; 288(5):E989-95. PubMed ID: 15613678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]